E-cadherin expression in canine malignant mammary tumours: relationship to other clinico-pathological variables

J Comp Pathol. 2006 Feb-Apr;134(2-3):182-9. doi: 10.1016/j.jcpa.2005.10.004. Epub 2006 Mar 20.

Abstract

The relationship between E-cadherin epithelial expression, as detected by immunohistochemical methods, and other clinico-pathological characteristics of canine malignant mammary tumours was studied in 77 tumours surgically removed from 45 female dogs. The immunohistochemical assessment was based on the estimated percentage of epithelial cells with membranous labelling. Reduction of E-cadherin expression was significantly related to size and ulceration of tumours but not to fixation to skin or underlying tissue; it was also related to lymph node metastasis, necrosis and infiltrative growth. Histological type (but not histological grade) was related to E-cadherin expression, with solid tumours more frequently lacking expression and tubulopapillary tumours showing increased expression as compared with the other types. The significant relationship between E-cadherin and other known factors of poor prognosis suggests that the loss of E-cadherin expression may have prognostic value in canine malignant mammary tumours.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biomarkers, Tumor / metabolism
  • Cadherins / metabolism*
  • Carcinoma / metabolism
  • Carcinoma / secondary
  • Carcinoma / veterinary*
  • Carcinosarcoma / metabolism
  • Carcinosarcoma / secondary
  • Carcinosarcoma / veterinary*
  • Dogs
  • Female
  • Immunoenzyme Techniques / methods
  • Immunoenzyme Techniques / veterinary
  • Lymph Nodes / metabolism
  • Lymph Nodes / pathology
  • Lymph Nodes / surgery
  • Lymphatic Metastasis
  • Mammary Glands, Animal / metabolism
  • Mammary Glands, Animal / pathology*
  • Mammary Glands, Animal / surgery
  • Mammary Neoplasms, Animal / metabolism
  • Mammary Neoplasms, Animal / pathology*
  • Mammary Neoplasms, Animal / surgery
  • Neoplasm Staging / veterinary

Substances

  • Biomarkers, Tumor
  • Cadherins